55 related articles for article (PubMed ID: 2503655)
1. [Identification, function mechanisms and regulation of potassium channels sensitive to ATP which are targets of sulfonylureas used in the treatment of type II diabetes mellitus].
Fosset M; De Weille J; Schmid-Antomarchi H; Bernardi H; Lazdunski M
Journ Annu Diabetol Hotel Dieu; 1989; ():7-11. PubMed ID: 2503655
[No Abstract] [Full Text] [Related]
2. ATP-sensitive potassium channels, transmural ischemia and the ECG implications for the non-insulin dependent diabetic patient?
Wilde AA
Cardiovasc Res; 1996 May; 31(5):688-90. PubMed ID: 8763397
[No Abstract] [Full Text] [Related]
3. [ATP-sensitive potassium channels and substances affecting them].
Pospísilová Y
Vnitr Lek; 1998 Jul; 44(7):435-8. PubMed ID: 9748883
[TBL] [Abstract][Full Text] [Related]
4. Sulphonylureas, magnesium and cardiac K+ ATP channels.
Matz R
Diabetologia; 2000 Aug; 43(8):1080-1. PubMed ID: 10990091
[No Abstract] [Full Text] [Related]
5. ATP-sensitive K+ channels and insulin secretion: their role in health and disease.
Ashcroft FM; Gribble FM
Diabetologia; 1999 Aug; 42(8):903-19. PubMed ID: 10491749
[No Abstract] [Full Text] [Related]
6. [Pharmacodynamics of second-generation sulfonylureas: dose-effect curve of gliquidone in type II diabetics].
Procacci V; Giovine A; Roberto MG; Ronchi AM; Lasorsa G; Vendemiale G; Stufano N; Altomare E
Boll Soc Ital Biol Sper; 1988 Aug; 64(8):731-8. PubMed ID: 3214573
[No Abstract] [Full Text] [Related]
7. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ
J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569
[TBL] [Abstract][Full Text] [Related]
8. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
9. Interactive regulation of the ATP-sensitive potassium channel of cardiac muscle.
Findlay I
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S6-11. PubMed ID: 7898107
[TBL] [Abstract][Full Text] [Related]
10. Sulfonylureas and mortality in diabetic patients after myocardial infarction.
Brady PA; Al-Suwaidi J; Kopecky SL; Terzic A
Circulation; 1998 Feb; 97(7):709-10. PubMed ID: 9495313
[No Abstract] [Full Text] [Related]
11. Unique natriuretic properties of the ATP-sensitive K(+)-channel blocker glyburide in conscious rats.
Clark MA; Humphrey SJ; Smith MP; Ludens JH
J Pharmacol Exp Ther; 1993 May; 265(2):933-7. PubMed ID: 8496833
[TBL] [Abstract][Full Text] [Related]
12. Use oral hypoglycemics with caution..
Jackson JE; Bressler R
Geriatrics; 1988 Aug; 43(8):77-83. PubMed ID: 3136057
[No Abstract] [Full Text] [Related]
13. [Mitochondrial ion channels].
Debska G; Kicińska A; Skalska J; Berest V; Szewczyk A
Postepy Hig Med Dosw; 2002; 56(3):315-21. PubMed ID: 12194244
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels].
Larsson O; Kindmark H; Bränström R; Berggren PO
Lakartidningen; 1997 Nov; 94(48):4473-7. PubMed ID: 9424548
[TBL] [Abstract][Full Text] [Related]
15. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
16. Cardiovascular effects of sulphonylurea derivatives.
Smits P
Diabetologia; 1997 Jul; 40 Suppl 2():S160-1. PubMed ID: 9248730
[No Abstract] [Full Text] [Related]
17. [ATP sensitive potassium channels--Kir6.2 gene].
Inagaki N; Seino S
Nihon Rinsho; 1997 Oct; 55 Suppl():452-7. PubMed ID: 9392148
[No Abstract] [Full Text] [Related]
18. Haemodynamic and other effects of sulphonylurea drugs on the heart.
Végh A; Papp JG
Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S43-53. PubMed ID: 8864640
[TBL] [Abstract][Full Text] [Related]
19. Ischemia in type 2 diabetes: tissue selectivity of sulfonylureas and clinical implications.
Wascher TC; Boes U
Metabolism; 2003 Aug; 52(8 Suppl 1):3-5. PubMed ID: 12939732
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ATP sensitive potassium channels.
de Weille JR
Cardiovasc Res; 1992 Nov; 26(11):1017-20. PubMed ID: 1291077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
